Myriad Genetics (MYGN) Current Deferred Tax Assets (2010 - 2015)

Myriad Genetics (MYGN) has reported Current Deferred Tax Assets for 6 consecutive years, with $13.5 million the latest figure, recorded in Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 2.05% year-over-year to $13.5 million; the TTM figure through Sep 2015 stood at $13.5 million (up 2.05% YoY), while the FY2015 annual figure was $13.5 million, up 107.69% from the prior year.
• Current Deferred Tax Assets was little changed at $13.5 million in Q3 2015 per MYGN's latest filing, from $13.5 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $13.5 million in Q2 2015 and bottomed at $4.4 million in Q1 2011.
• Historically, Current Deferred Tax Assets has averaged $9.2 million across 5 years, with a median of $8.8 million in 2013.
• Annual changes were most pronounced in 2011 — Current Deferred Tax Assets sank 47.25% — and 2015, when it surged 107.69%.
• Myriad Genetics' Current Deferred Tax Assets stood at $7.8 million in 2011, then grew by 20.14% to $9.4 million in 2012, then slipped by 2.99% to $9.1 million in 2013, then jumped by 41.21% to $12.8 million in 2014, then rose by 5.36% to $13.5 million in 2015.
• Business Quant data shows MYGN's Current Deferred Tax Assets at $13.5 million in Q3 2015, $13.5 million in Q2 2015, and $13.5 million in Q1 2015.